{"id":"qiliqiangxin-capsule","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL206253","moleculeType":"Small molecule","molecularWeight":"578.60"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Qiliqiangxin contains a blend of traditional Chinese herbs formulated to enhance myocardial contractility, reduce cardiac remodeling, and suppress inflammatory pathways implicated in heart failure progression. The preparation works through multiple mechanisms including inhibition of TNF-α and other pro-inflammatory cytokines, improvement of cardiac energy metabolism, and reduction of myocardial fibrosis.","oneSentence":"Qiliqiangxin is a traditional Chinese medicine capsule that improves cardiac function and reduces heart failure symptoms through multi-target anti-inflammatory and cardioprotective effects.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:03:22.022Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic heart failure"},{"name":"Congestive heart failure with reduced ejection fraction"}]},"trialDetails":[{"nctId":"NCT01293903","phase":"PHASE4","title":"Study of Qiliqiangxin Capsule to Treat Dilated Cardiomyopathy","status":"COMPLETED","sponsor":"Huazhong University of Science and Technology","startDate":"2012-01","conditions":"Dilated Cardiomyopathy, Heart Failure","enrollment":374},{"nctId":"NCT02283450","phase":"","title":"Regulation of Immunological Cytokines by Qiliqiangxin Capsule in Dilated Cardiomyopathy Patients","status":"COMPLETED","sponsor":"Harbin Medical University","startDate":"2012-05","conditions":"Congestive Heart Failure","enrollment":30}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"BRAIN CONTUSION"},{"count":1,"reaction":"BRAIN INJURY"},{"count":1,"reaction":"CRANIOCEREBRAL INJURY"},{"count":1,"reaction":"GLOMERULONEPHRITIS CHRONIC"},{"count":1,"reaction":"SUBARACHNOID HAEMORRHAGE"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Qiliqiangxin Capsule","genericName":"Qiliqiangxin Capsule","companyName":"Harbin Medical University","companyId":"harbin-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Qiliqiangxin is a traditional Chinese medicine capsule that improves cardiac function and reduces heart failure symptoms through multi-target anti-inflammatory and cardioprotective effects. Used for Chronic heart failure, Congestive heart failure with reduced ejection fraction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}